Xencor Inc
XNCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326732
No open-market purchases or sales by Xencor Inc insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Xencor Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 195
- +18 vs. Q3 2023
- Shares held
- 63.4M
- +197.5K (+0.3%) vs. Q3 2023
- Total value
- $1.35B
- +$72.5M (+5.7%) vs. Q3 2023
- New holders
- 35
- 76 more added
- Sold out
- 17
- 57 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XNCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $1.36B |
| Q1 2026 | 203 | $1.02B |
| Q4 2025 | 208 | $1.25B |
| Q3 2025 | 206 | $960.2M |
| Q2 2025 | 194 | $646.9M |
| Q1 2025 | 202 | $837.9M |
| Q4 2024 | 192 | $1.72B |
| Q3 2024 | 210 | $1.45B |
| Q2 2024 | 198 | $1.20B |
| Q1 2024 | 201 | $1.44B |
| Q4 2023 | 195 | $1.35B |
| Q3 2023 | 178 | $1.27B |
| Q2 2023 | 182 | $1.57B |
| Q1 2023 | 188 | $1.77B |
| Q4 2022 | 197 | $1.60B |
| Q3 2022 | 186 | $1.58B |
| Q2 2022 | 176 | $1.64B |
| Q1 2022 | 181 | $1.58B |
| Q4 2021 | 178 | $2.37B |
| Q3 2021 | 170 | $1.90B |
| Q2 2021 | 178 | $2.00B |
| Q1 2021 | 170 | $2.52B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Xencor Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AE Wealth Management LLC | 0 | $0 | 0.00% | −24,889−100.0% | Sold out |
| Mach-1 Financial Group, Inc. | 0 | $0 | 0.00% | −24,817−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,285−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −21,223−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −19,142−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −13,102−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,591−100.0% | Sold out |
| Virtus Investment Advisers, Inc. | 0 | $0 | 0.00% | −7,596−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,468−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,740−100.0% | Sold out |
| BluePath Capital Management, LLC | 0 | $0 | 0.00% | −1,531−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Steward Financial Group LLC | – | – | – | – | Not filed |